StimLabs
8
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
37.5%
3 terminated/withdrawn out of 8 trials
25.0%
-61.6% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds
Role: lead
Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds
Role: lead
Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs
Role: lead
Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal DFUs
Role: lead
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
Role: lead
Efficacy of a Full-Thickness Placental Allograft in Lumbar Microdiscectomy
Role: lead
Efficacy of Human Placental Graft in Diabetic Foot Ulcers
Role: lead
Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid
Role: lead
All 8 trials loaded